http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005039482-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac3e787a6871df4284213bb52de1883d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26fb8f845a9b471a43f62c58f5b7a566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f625e98bcc4cbcf82e4396a6c0de754a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate 2003-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d1fdb9a593b02507e0e65f4f405a324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90f49c6d94e5abe4039b84f27292e54b
publicationDate 2005-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005039482-A2
titleOfInvention Utilization of vinpocetine to avoid complications in particular those associated to hearing which occur with epilepsy, and treatment thereof
abstract The present invention relates to the utilization of vinpocetine and the derivatives thereof which can be develop while keeping the same effects for the treatment of epilepsy and its complications. The results obtained show that vinpocetine inhibits all alterations of waves of RATC which accompany the cortical epileptic activity during the ictal and post-ictal period in two experimental models of epilepsy in vivo, that vinpocetine also inhibits the marked loss of hearing and the characteristics changes of EEG which are induced by two convulsive agents which differ in their action mechanism. These findings indicate that the capacity of vinpocetine as antiepileptic drug has no adverse secondary effects.
priorityDate 2003-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135735641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10219440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405765
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433619
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443955
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226784193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394197

Total number of triples: 45.